PharmaCyte Biotech annual meeting elects directors, ratifies auditor, approves exec compensation

PharmaCyte Biotech, Inc.

Annual meeting held Apr 24, 2025; quorum of 3,222,988 shares (~46.92%) present.
All five director nominees elected: Silverman, Schechter, Abecassis, Weinstein, Walker.
CBIZ CPAs P.C. ratified as auditor for FY ending Apr 30, 2025 (for: 3,123,042; against: 72,371).
Non-binding advisory vote approved executive compensation (for: 1,094,399; against: 113,815; abstain: 21,543).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.